Activation of peripheral ATP-sensitive K+ channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom

European Journal of Pharmacology

Volumn 469, Issue 1-3, 2003, Pages 57-64

  Picolo, Gisele ^a   Cassola, Antônio Carlos ^b   Cury, Yara ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Analgesia; ATP sensitive K+ channel; Crotalus durissus terrificus venom; Opioid receptor agonist, peripheral; Opioid receptor agonist, peripheral

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CARRAGEENAN; CHARYBDOTOXIN; DELTA OPIATE RECEPTOR AGONIST; DIAZOXIDE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GLIBENCLAMIDE; KAPPA OPIATE RECEPTOR AGONIST; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; PROSTAGLANDIN E2; SNAKE VENOM; TETRYLAMMONIUM;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONOSEQUENCE; DRUG ACTIVITY; DRUG EFFECT; ELECTRIC POTENTIAL; EXPERIMENTAL MODEL; HYPERALGESIA; INHIBITION KINETICS; INJECTION; MALE; NONHUMAN; PAIN THRESHOLD; PRESSURE; PRIORITY JOURNAL; RAT; SENSORY NERVE;

EID: 0037716325     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01676-5     Document Type: Article

References (30)

1. + channels. Science. 247:1990;852-854.
2. Brigatte P., Hoffmann F.A., Bernardi M.M., Giorgi R., Fernandes I., Takehara H.A., Barros S.B.M., Almeida M.G., Cury Y. Tolerance to the antinociceptive effect of Crotalus durissus terrificus snake venom in mice is mediate by pharmacodynamic mechanisms. Toxicon. 39:2001;1399-1410.
3. Cook N.S., Quast U. Potassium channel pharmacology. Cook N.S. Potassium Channels: Structure, Classification, Function and Therapeutic Potential. 1990;181-255 Ellis Horwood, Chichester.
4. + channels of muscle cells - their properties, regulation and functions. J. Bioenerg. Biomembranes. 23:1991;509-535.
5. + channels. Annu. Rev. Pharmacol. Toxicol. 33:1993;597-637.
6. Ferreira S.H., Duarte I.D.G., Lorenzetti B.B. Molecular base of acetylcholine and morphine analgesia. Drug in Inflammation. 1991;101-106 Birkhäuser Verlag, Basel.
7. Ferreira S.H., Duarte I.D.G., Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of cGMP system via nitric oxide release. Eur. J. Pharmacol. 1217:1991;225-227.
8. Giorgi R., Bernardi M.M., Cury Y. Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom. Toxicon. 31:1993;1257-1265.
9. Granados-Soto V., Rufino M.O., Lopes L.D.G., Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 340:1997;177-180.
10. + channel pathway in the antinociceptive action of ketorolac. Eur. J. Pharmacol. 426:2001;39-44.
11. + channels from mammalian skeletal muscle. Nature. 313:1985;316-318.
12. + channels in the cardiovascular system. Am. J. Physiol. 261:1991;H1675-H1686.
13. North R.A. Opioid action on membrane ion channels. Herz A. Handbook of Experimental Pharmacology. Opioid I. vol. 104/I:1993;773-793 Springer, Berlin.
14. Nozaki-Taguchi N., Yamamoto T. Involvement of nitric oxide in peripheral antinociception mediated by κ and δ-opioid receptors. Anesth. Analg. 87:1998;388-393.
15. + channels by diclofenac. Eur. J. Pharmacol. 438:2002;85-91.
16. Picolo G., Giorgi R., Cury Y. δ-Opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol. 391:2000;55-62.
17. + channel openers, diazoxide and cromakalim, and their inhibition by glybenclamide. J. Pharmacol. Exp. Ther. 250:1989;261-271.
18. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 111:1957;209-219.
19. + channels. Br. J. Pharmacol. 129:2000;110-114.
20. + channels. J. Physiol. (Paris). 79:1984;259-264.
21. Schultz J.E.J., Gross G.J. Opioids and cardioprotection. Pharmacol. Ther. 89:2001;123-137.
22. 2-induced hyperalgesic paw. Br. J. Pharmacol. 134:2001;127-131.
23. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol. 400:2000;67-71.
24. Sokal R.R., Rohlf F.J. Biometry. 1981;859 Freeman, New York, NY.
25. Steinberg M.I., Ertel P., Smallwood J.K., Wyss V., Zimmerman K. The relation between vascular relaxant and cardiac electrophysiological effects of pinacidil. J. Cardiovasc. Pharmacol. 12:1988;S30-S40.
26. Stretton D., Miura M., Bevisi M.G., Barnes P.J. Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Proc. Natl. Acad. Sci. U. S. A. 9:1992;1325-1329.
27. Welch S., Dunlow L.D. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J. Pharmacol. Exp. Ther. 267:1993;390-399.
28. Wild K.D., Vanderah T., Mosberg H.I., Porreca F. Opioid δ receptor subtypes are associated with different potassium channels. Eur. J. Pharmacol. 193:1991;135-136.
29. Yonehara N., Takiuchi S. Involvement of calcium-activated potassium channels in the inhibitory prejunctional effect of morphine on peripheral sensory nerves. Regul. Pept. 68:1997;147-153.
30. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.